Monica Bertagnolli left the role of Director at Natera, Inc., effective July 1, 2026. As of November 7, 2026, Natera, Inc. has reported 4 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 1, 2026 to July 6, 2026, naming 6 appointments and 1 departure (Form 8-K, July 6, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Natera, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Out · Person: Monica Bertagnolli · Role: Director · Effective: 2026-07-01 · 8-K, 2026-07-06
- · In / out: In · Person: Thomas Lynch · Role: Director · Effective: 2026-06-02 · 8-K/A, 2026-06-16
- · In / out: In · Person: Thomas Lynch · Role: Director · Effective: 2026-06-02 · 8-K, 2026-06-05
- · In / out: In · Person: Eric Rubin · Role: Director · Effective: 2026-03-26 · 8-K, 2026-04-01
Natera, Inc. reported changes in 4 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-01 to 2026-07-06. They name 3 people, with 6 appointments and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Natera, Inc. files it.
Also on the record for Natera, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 6, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 10.5% of the class | 5%+ stakes | Source |
| November 5, 2026 | Stake report, Schedule 13G, by FMR LLC | 9.5% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by T. Rowe Price Associates, Inc. | 6.3% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.08% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by T. Rowe Price Associates, Inc. | 7.8% of the class | 5%+ stakes | Source |
| January 23, 2026 | Stake report, Schedule 13G/A, by JPMORGAN CHASE & CO. | 9.1% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G/A, by T. Rowe Price Associates, Inc. | 8.9% of the class | 5%+ stakes | Source |
| July 22, 2025 | Stake report, Schedule 13G/A, by JPMORGAN CHASE & CO. | 7.7% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Natera, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Natera, Inc. and the records around it.
Natera, Inc. elsewhere on the record
Companies that share a holder
- JPMORGAN CHASE & CO. also filed stake reports on 116 other companies: LEVI STRAUSS & CO (Nov 2026), Warner Music Group Corp. (Nov 2026), Andersen Group Inc. (Oct 2026)
- T. Rowe Price Associates, Inc. also filed stake reports on 191 other companies: PACIFIC BIOSCIENCES OF CALIF (Nov 2026), APARTMENT INVT & MGMT CO -A (Oct 2026), BETA BIONICS INC (Oct 2026)
- FMR LLC also filed stake reports on 761 other companies: ASPEN NEUROSCIENCE INC (Nov 2026), AVALO THERAPEUTICS INC (Nov 2026), BRAZE INC (Nov 2026)
Watch Natera, Inc.
Get an email when Natera, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Natera, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Natera, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Natera, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-07-06 | Out | Director | 2026-07-01 | 8-K, 2026-07-06 | |
| 2026-06-16 | In | Director | 2026-06-02 | 8-K/A, 2026-06-16 | |
| 2026-06-16 | In | 8-K/A, 2026-06-16 | |||
| 2026-06-05 | In | Director | 2026-06-02 | 8-K, 2026-06-05 | |
| 2026-06-05 | In | 8-K, 2026-06-05 | |||
| 2026-04-01 | In | Director | 2026-03-26 | 8-K, 2026-04-01 | |
| 2026-04-01 | In | 8-K, 2026-04-01 |
Who leads Natera, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Monica Bertagnolli, departure reported, effective 2026-07-01 (filed 2026-07-06). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Natera, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Natera, Inc., with the record behind each one.
Find candidates like Director at Natera, Inc.Every change, in the filing's words
Departing: Monica Bertagnolli, Director, effective 2026-07-01
On July 1, 2026, Monica Bertagnolli notified the Board of Directors (the "Board") of Natera, Inc. ("Natera" or the "Company") of her intention to resign as a member of the Board and any committees of the Board, effective July 1, 2026, due to her new position with the National Academy of Medicine.
- Ms. Bertagnolli's resignation was not a result of any disagreement with the Company on any matter relating to its operations, policies or practices.
Appointed: Thomas Lynch, Director, effective 2026-06-02
The Board of Directors (the "Board") of Natera, Inc., a Delaware corporation (the "Company") (i) increased the size of the full Board from eleven to twelve members and (ii) appointed Thomas Lynch as a member of the Board, in each case effective as of June 2, 2026.
Appointed: Thomas Lynch
The Board has appointed Dr. Lynch to the Human Capital Committee of the Board.
- Dr. Lynch will serve as a Class I director, with an initial term expiring at the 2028 annual meeting of stockholders.
- The Board determined that Dr. Lynch qualifies as an independent director pursuant to the Securities Act of 1933, as amended, and the listing standards of The Nasdaq Stock Market.
- In connection with his appointment to the Board, Dr. Lynch will be entitled to receive cash and equity compensation consistent with that of the Company's other non-employee directors.
- The Company also expects to enter into an Indemnification Agreement with Dr. Lynch, providing for indemnification and advancement of litigation and other expenses to Dr. Lynch to the fullest extent permitted by law for claims relating to his service to the Company or its subsidiaries.
Appointed: Thomas Lynch, Director, effective 2026-06-02
The Board of Directors (the "Board") of Natera, Inc., a Delaware corporation (the "Company") (i) increased the size of the full Board from eleven to twelve members and (ii) appointed Thomas Lynch as a member of the Board, in each case effective as of June 2, 2026.
Appointed: Thomas Lynch
The Board has appointed Dr. Lynch to the Human Capital Committee of the Board.
- Dr. Lynch will serve as a Class I director, with an initial term expiring at the 2028 annual meeting of stockholders.
- The Board determined that Dr. Lynch qualifies as an independent director pursuant to the Securities Act of 1933, as amended, and the listing standards of The Nasdaq Stock Market.
- In connection with his appointment to the Board, Dr. Lynch will be entitled to receive cash and equity compensation consistent with that of the Company's other non-employee directors.
- The Company also expects to enter into an Indemnification Agreement with Dr. Lynch, providing for indemnification and advancement of litigation and other expenses to Dr. Lynch to the fullest extent permitted by law for claims relating to his service to the Company or its subsidiaries.
Appointed: Eric Rubin, Director, effective 2026-03-26
The Board of Directors (the "Board") of Natera, Inc., a Delaware corporation (the "Company"), based on the recommendation of the Board's Nominating, Corporate Governance and Compliance Committee, (i) increased the size of the full Board from ten to eleven members and (ii) appointed Eric Rubin as a member of the Board, in each case effective as of March 26, 2026.
Appointed: Eric Rubin
The Board has appointed Dr. Rubin to the Nominating, Corporate Governance and Compliance Committee of the Board.
- Dr. Rubin will serve as a Class I director, with an initial term expiring at the 2028 annual meeting of stockholders.
- The Board determined that Dr. Rubin qualifies as an independent director pursuant to the Securities Act of 1933, as amended, and the listing standards of The Nasdaq Stock Market.
- In connection with his appointment to the Board, Dr. Rubin will be entitled to receive cash and equity compensation consistent with that of the Company's other non-employee directors.
- The Company also entered into an Indemnification Agreement with Dr. Rubin, providing for indemnification and advancement of litigation and other expenses to Dr. Rubin to the fullest extent permitted by law for claims relating to his service to the Company or its subsidiaries.
Tools for this story
Each opens in a new tab, filled in for Natera, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.